
About Medisafe Inc.
Medisafe datasets capture medication management consumption behavior around adherence including within drug classes across different brands and granular details on scheduled dosing and reasons for non-adherence. The behavioral-driven data provides insights into healthcare consumption in a de-identified and HIPAA compliant manner. Data sourced from self-reported medication management behaviors is valuable research for the development of future healthcare advancements from drug discovery to care management and delivery programs.
showing 1 - 10
- Sold by Medisafe Inc.
Price $36,000 | 12 month subscription available.
Gain actionable insights by tracking trends, commonalities and outliers from a cross-section of medication class populations. Sourced from self-reported and de-identified data this product provides valuable insights about med combination trends.
- Sold by Medisafe Inc.
Price $24,000 | 12 month subscription available.
Examine daily medication consumption patterns of self-reported and de-identified patients taking antidepressants: SNRIs to gain insight about specific behaviors. The snapshot includes detailed breakdown of adherence/persistence data by medication, including overdosing, number and timeliness of missed doses and duration of medication intake.
- Sold by Medisafe Inc.
Free | 12 month subscription available.
A complementary file to the "Non-adherence reasons" products. This file contains a mapping between survey answers to responses presented to users.
- Sold by Medisafe Inc.
Price $36,000 | 12 month subscription available.
Gain actionable insights by tracking trends, commonalities and outliers from a cross-section of medication class populations. Sourced from self-reported and de-identified data this product provides valuable insights about med combination trends.
- Sold by Medisafe Inc.
Price $36,000 | 12 month subscription available.
Examine medication consumption patterns in granular, down to the hour, details of self-reported and de-identified patients taking Oncology: Immunomodulators to gain insight about specific behaviors.
- Sold by Medisafe Inc.
Price $36,000 | 12 month subscription available.
Examine medication consumption patterns in granular, down to the hour, details of self-reported and de-identified patients taking DPP-4 Inhibitors in combination with additional medications to gain insight about specific behaviors.
- Sold by Medisafe Inc.
Price $36,000 | 12 month subscription available.
Gain actionable insights by tracking trends, commonalities and outliers from a cross-section of medication class populations. Sourced from self-reported and de-identified data this product provides valuable insights about med combination trends.
- Sold by Medisafe Inc.
Price $24,000 | 12 month subscription available.
Examine daily medication consumption patterns of self-reported and de-identified patients taking Immunomodulators to gain insight about specific behaviors. The snapshot includes detailed breakdown of adherence/persistence data by medication, including overdosing, number and timeliness of missed doses and duration of medication intake.
- Sold by Medisafe Inc.
Price $24,000 | 12 month subscription available.
Examine daily medication consumption patterns of self-reported and de-identified patients taking an immunomodulator to gain insight about specific behaviors. The snapshot includes detailed breakdown of adherence/persistence data by medication, including overdosing, number and timeliness of missed doses and duration of medication intake.
- Sold by Medisafe Inc.
Free | 12 month subscription available.
This file contains a list of key terms and metrics with definitions relevant to the data products posted here.
showing 1 - 10